3 results
Approved WMOCompleted
To evaluate whether SAH patients treated by state-of-the-art SAH management with additional ultra-early and short term TXA administration have a significantly higher percentage of favourable outcome after six months (score 0-3 on the Modified Rankin…
Approved WMOCompleted
to determine the normal FGF23 response in case of hypophosphatemia
Approved WMOCompleted
To evaluate management strategies in premenopausal women with heavy menstrual bleeding associated with factor Xa inhibitor therapy.